Redhill Biopharma
RDHL
#11160
Rank
A$3.77 M
Marketcap
A$0.42
Share price
-13.08%
Change (1 day)
-74.38%
Change (1 year)

Redhill Biopharma (RDHL) - Net assets

Net assets on the balance sheet as of June 2026 : -A$1.64 Million

According to Redhill Biopharma's latest financial reports the company has -A$1.64 Million in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Redhill Biopharma - Net assets on balance sheet (from 2011 to 2026)

Net assets by year

Year Net assets Change
2025-12-31$A$6.37 M-184.63%
2024-12-31$-A$7.53 Million-347.92%
2023-12-31$A$3.03 M-104.27%
2022-12-31$-A$71.13 Million-681%
2021-12-31$A$12.24 M-32.1%
2020-12-31$A$18.03 M-78.96%
2019-12-31$A$85.7 M17.95%
2018-12-31$A$72.65 M25.87%
2017-12-31$A$57.72 M-33.64%
2016-12-31$A$86.98 M5.48%
2015-12-31$A$82.46 M169.85%
2014-12-31$A$30.56 M128.59%
2013-12-31$A$13.36 M-26.95%
2012-12-31$A$18.3 M-0.12%
2011-12-31$A$18.32 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Sanofi
SNY
A$119.95 B-7,358,672.75%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
A$63.42 B-3,891,110.19%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$36.79 B-2,257,375.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
A$11.71 B-719,006.39%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Taro Pharmaceutical
TARO
A$2.68 B-164,983.23%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel